-
1
-
-
47249094575
-
Developing idiotype vaccines for lymphoma: From preclinical studies to phase III clinical trials
-
DOI 10.1111/j.1365-2141.2008.07143.x
-
Park HJ, Neelapu SS. Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials. Br J Haematol 2008;142:179-91. (Pubitemid 351987313)
-
(2008)
British Journal of Haematology
, vol.142
, Issue.2
, pp. 179-191
-
-
Park, H.J.1
Neelapu, S.S.2
-
2
-
-
63449100805
-
Vaccines for lymphomas: Idiotype vaccines and beyond
-
Houot R, Levy R. Vaccines for lymphomas: idiotype vaccines and beyond. Blood Rev 2009;23:137-42.
-
(2009)
Blood Rev
, vol.23
, pp. 137-142
-
-
Houot, R.1
Levy, R.2
-
3
-
-
0030026776
-
Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
-
DOI 10.1038/nm0196-52
-
Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taidi B, et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 1996;2:52-8. (Pubitemid 26028073)
-
(1996)
Nature Medicine
, vol.2
, Issue.1
, pp. 52-58
-
-
Hsu, F.J.1
Benike, C.2
Fagnoni, F.3
Liles, T.M.4
Czerwinski, D.5
Taidi, B.6
Engleman, E.G.7
Levy, R.8
-
4
-
-
0029899641
-
Tumor-specific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma
-
Nelson EL, Li X, Hsu FJ, Kwak LW, Levy R, Clayberger C, et al. Tumorspecific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma. Blood 1996;88:580-9. (Pubitemid 26240390)
-
(1996)
Blood
, vol.88
, Issue.2
, pp. 580-589
-
-
Nelson, E.L.1
Li, X.2
Hsu, F.J.3
Kwak, L.W.4
Levy, R.5
Clayberger, C.6
Krensky, A.M.7
-
5
-
-
0032828653
-
Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma
-
DOI 10.1038/13928
-
Bendandi M, Gocke CD, Kobrin CB, Benko FA, Sternas LA, Pennington R, et al. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nat Med 1999;5:1171-7. (Pubitemid 29474422)
-
(1999)
Nature Medicine
, vol.5
, Issue.10
, pp. 1171-1177
-
-
Bendandi, M.1
Gocke, C.D.2
Kobrin, C.B.3
Benko, F.A.4
Sternas, L.A.5
Pennington, R.6
Watson, T.M.7
Reynolds, C.W.8
Gause, B.L.9
Duffey, P.L.10
Jaffe, E.S.11
Creekmore, S.P.12
Longo, D.L.13
Kwak, L.W.14
-
6
-
-
0036493712
-
Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: Clinical and immune responses in 35 patients
-
DOI 10.1182/blood.V99.5.1517
-
Timmerman JM, Czerwinski DK, Davis TA, Hsu FJ, Benike C, Hao ZM, et al. Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients. Blood 2002;99:1517-26. (Pubitemid 34533020)
-
(2002)
Blood
, vol.99
, Issue.5
, pp. 1517-1526
-
-
Timmerman, J.M.1
Czerwinski, D.K.2
Davis, T.A.3
Hsu, F.J.4
Benike, C.5
Hao, Z.M.6
Taidi, B.7
Rajapaksa, R.8
Caspar, C.B.9
Okada, C.Y.10
Van Beckhoven, A.11
Liles, T.M.12
Engleman, E.G.13
Levy, R.14
-
7
-
-
14544301233
-
Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype
-
Weng WK, Czerwinski D, Timmerman J, Hsu FJ, Levy R. Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype. J Clin Oncol 2004;22:4717-24.
-
(2004)
J Clin Oncol
, vol.22
, pp. 4717-4724
-
-
Weng, W.K.1
Czerwinski, D.2
Timmerman, J.3
Hsu, F.J.4
Levy, R.5
-
8
-
-
33749005382
-
Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma
-
DOI 10.1093/jnci/djj358
-
Inoges S, Rodriguez-Calvillo M, Zabalegui N, Lopez-Diaz de CA, Villanueva H, Soria E, et al. Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma. J Natl Cancer Inst 2006;98:1292-301. (Pubitemid 44530725)
-
(2006)
Journal of the National Cancer Institute
, vol.98
, Issue.18
, pp. 1292-1301
-
-
Inoges, S.1
Rodriguez-Calvillo, M.2
Zabalegui, N.3
Lopez-Diaz De, C.A.4
Villanueva, H.5
Soria, E.6
Suarez, L.7
Rodriguez-Caballero, A.8
Pastor, F.9
Garcia-Munoz, R.10
Panizo, C.11
Perez-Calvo, J.12
Melero, I.13
Rocha, E.14
Orfao, A.15
Bendandi, M.16
-
9
-
-
79958264390
-
Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma
-
Schuster SJ, Neelapu SS, Gause BL, Janik JE, Muggia FM, Gockerman JP, et al. Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma. J Clin Oncol 2011;29:2787-94.
-
(2011)
J Clin Oncol
, vol.29
, pp. 2787-2794
-
-
Schuster, S.J.1
Neelapu, S.S.2
Gause, B.L.3
Janik, J.E.4
Muggia, F.M.5
Gockerman, J.P.6
-
10
-
-
59249096051
-
Idiotype vaccination for lymphoma: Moving towards optimisation
-
Houot R, Levy R. Idiotype vaccination for lymphoma: moving towards optimisation. Leuk Lymphoma 2009;50:1-2.
-
(2009)
Leuk Lymphoma
, vol.50
, pp. 1-2
-
-
Houot, R.1
Levy, R.2
-
11
-
-
0034670010
-
Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia
-
De Re V, De Vita S, Marzotto A, Rupolo M, Gloghini A, Pivetta B, et al. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 2000;96:3578-84.
-
(2000)
Blood
, vol.96
, pp. 3578-3584
-
-
De Re, V.1
De Vita, S.2
Marzotto, A.3
Rupolo, M.4
Gloghini, A.5
Pivetta, B.6
-
12
-
-
0035865521
-
H1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen
-
DOI 10.1182/blood.V97.4.1023
-
Chan CH, Hadlock KG, Foung SK, Levy S. V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen. Blood 2001;97:1023-6. (Pubitemid 32154288)
-
(2001)
Blood
, vol.97
, Issue.4
, pp. 1023-1026
-
-
Chan, C.H.1
Hadlock, K.G.2
Foung, S.K.H.3
Levy, S.4
-
13
-
-
0036207634
-
Salivary gland B cell lymphoproliferative disorders in Sjogren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkin's lymphomas
-
DOI 10.1002/1521-4141(200203)32:3<903::AID-IMMU903>3.0.CO;2-D
-
De Re V, De Vita S, Gasparotto D, Marzotto A, Carbone A, Ferraccioli G, et al. Salivary gland B cell lymphoproliferative disorders in Sjogren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas. Eur J Immunol 2002;32:903-10. (Pubitemid 34257568)
-
(2002)
European Journal of Immunology
, vol.32
, Issue.3
, pp. 903-910
-
-
De Re, V.1
De Vita, S.2
Gasparotto, D.3
Marzotto, A.4
Carbone, A.5
Ferraccioli, G.6
Boiocchi, M.7
-
14
-
-
0032055530
-
Somatic hypermutation, clonal diversity, and preferential expression of the V(H) 51p1/V(L) kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas
-
Ivanovski M, Silvestri F, Pozzato G, Anand S, Mazzaro C, Burrone OR, et al. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 1998;91:2433-42. (Pubitemid 28155518)
-
(1998)
Blood
, vol.91
, Issue.7
, pp. 2433-2442
-
-
Ivanovski, M.1
Silvestri, F.2
Pozzato, G.3
Anand, S.4
Mazzaro, C.5
Burrone, O.R.6
Efremov, D.G.7
-
15
-
-
1842290375
-
Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression
-
DOI 10.1002/eji.1830270616
-
Kuppers R, Rajewsky K, Hansmann ML. Diffuse large cell lymphomas are derived from matureBcells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression. Eur J Immunol 1997;27:1398-405. (Pubitemid 27254831)
-
(1997)
European Journal of Immunology
, vol.27
, Issue.6
, pp. 1398-1405
-
-
Kuppers, R.1
Rajewsky, K.2
Hansmann, M.-L.3
-
16
-
-
18244385722
-
Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity
-
DOI 10.1084/jem.20050068
-
Bende RJ, Aarts WM, Riedl RG, de JD, Pals ST, van Noesel CJ. Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J Exp Med 2005;201:1229-41. (Pubitemid 40629067)
-
(2005)
Journal of Experimental Medicine
, vol.201
, Issue.8
, pp. 1229-1241
-
-
Bende, R.J.1
Aarts, W.M.2
Riedl, R.G.3
De Jong, D.4
Pals, S.T.5
Van Noesel, C.J.M.6
-
17
-
-
77449108587
-
Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins
-
Craig VJ, Arnold I, Gerke C, Huynh MQ, Wundisch T, Neubauer A, et al. Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins. Blood 2010;115:581-91.
-
(2010)
Blood
, vol.115
, pp. 581-591
-
-
Craig, V.J.1
Arnold, I.2
Gerke, C.3
Huynh, M.Q.4
Wundisch, T.5
Neubauer, A.6
-
18
-
-
48749100416
-
Immunoglobulin kappa gene repertoire and somatic hypermutation patterns in follicular lymphoma
-
Smilevska T, Tsakou E, Hadzidimitriou A, Bikos V, Stavroyianni N, Laoutaris N, et al. Immunoglobulin kappa gene repertoire and somatic hypermutation patterns in follicular lymphoma. Blood Cells Mol Dis 2008;41:215-8.
-
(2008)
Blood Cells Mol Dis
, vol.41
, pp. 215-218
-
-
Smilevska, T.1
Tsakou, E.2
Hadzidimitriou, A.3
Bikos, V.4
Stavroyianni, N.5
Laoutaris, N.6
-
19
-
-
7244232709
-
Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia
-
DOI 10.1182/blood-2004-01-0132
-
Tobin G, Thunberg U, Karlsson K, Murray F, Laurell A, Willander K, et al. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 2004;104:2879-85. (Pubitemid 39434975)
-
(2004)
Blood
, vol.104
, Issue.9
, pp. 2879-2885
-
-
Tobin, G.1
Thunberg, U.2
Karlsson, K.3
Murray, F.4
Laurell, A.5
Willander, K.6
Enblad, G.7
Merup, M.8
Vilpo, J.9
Juliusson, G.10
Sundstrom, C.11
Soderberg, O.12
Roos, G.13
Rosenquist, R.14
-
20
-
-
27744598787
-
Immunoglobulin light chain repertoire in chronic lymphocytic leukemia
-
DOI 10.1182/blood-2005-04-1511
-
Stamatopoulos K, Belessi C, Hadzidimitriou A, Smilevska T, Kalagiakou E, Hatzi K, et al. Immunoglobulin light chain repertoire in chronic lymphocytic leukemia. Blood 2005;106:3575-83. (Pubitemid 41609196)
-
(2005)
Blood
, vol.106
, Issue.10
, pp. 3575-3583
-
-
Stamatopoulos, K.1
Belessi, C.2
Hadzidimitriou, A.3
Smilevska, T.4
Kalagiakou, E.5
Hatzi, K.6
Stavroyianni, N.7
Athanasiadou, A.8
Tsompanakou, A.9
Papadaki, T.10
Kokkini, G.11
Paterakis, G.12
Saloum, R.13
Laoutaris, N.14
Anagnostopoulos, A.15
Fassas, A.16
-
21
-
-
69949136109
-
Characterization of antibodies directed against the immunoglobulin light kappa chain variable chain region (VK) of hepatitis C virus-related type-II mixed cryoglobulinemia and B-cell proliferations
-
De Re V, Simula MP, Pavan A, Garziera M, Marin D, Dolcetti R, et al. Characterization of antibodies directed against the immunoglobulin light kappa chain variable chain region (VK) of hepatitis C virus-related type-II mixed cryoglobulinemia and B-cell proliferations. Ann N Y Acad Sci 2009;1173:152-60.
-
(2009)
Ann N Y Acad Sci
, vol.1173
, pp. 152-160
-
-
De Re, V.1
Simula, M.P.2
Pavan, A.3
Garziera, M.4
Marin, D.5
Dolcetti, R.6
-
22
-
-
33744487471
-
Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: Evidence from GeneScan and MALDI-TOF analyses
-
DOI 10.1093/rheumatology/kei278
-
De Re V, De Vita S, Sansonno D, Gasparotto D, Simula MP, Tucci FA, et al. Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses. Rheumatology (Oxford) 2006;45:685-93. (Pubitemid 43985336)
-
(2006)
Rheumatology
, vol.45
, Issue.6
, pp. 685-693
-
-
De Re, V.1
De Vita, S.2
Sansonno, D.3
Gasparotto, D.4
Simula, M.P.5
Tucci, F.A.6
Marzotto, A.7
Fabris, M.8
Gloghini, A.9
Carbone, A.10
Dammacco, F.11
Boiocchi, M.12
-
23
-
-
47249092365
-
Spontaneous T cell responses to Epstein-Barr virus-encoded BARF1 protein and derived peptides in patients with nasopharyngeal carcinoma: Bases for improved immunotherapy
-
Martorelli D, Houali K, Caggiari L, Vaccher E, Barzan L, Franchin G, et al. Spontaneous T cell responses to Epstein-Barr virus-encoded BARF1 protein and derived peptides in patients with nasopharyngeal carcinoma: bases for improved immunotherapy. Int J Cancer 2008;123:1100-7.
-
(2008)
Int J Cancer
, vol.123
, pp. 1100-1107
-
-
Martorelli, D.1
Houali, K.2
Caggiari, L.3
Vaccher, E.4
Barzan, L.5
Franchin, G.6
-
24
-
-
84925548986
-
The instructive role of dendritic cells on T-cell responses
-
Sallusto F, Lanzavecchia A. The instructive role of dendritic cells on T-cell responses. Arthritis Res 2002;4 Suppl 3:S127-32.
-
(2002)
Arthritis Res
, vol.4
, Issue.SUPPL. 3
-
-
Sallusto, F.1
Lanzavecchia, A.2
-
25
-
-
0020546352
-
The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells
-
Russo C, Ng AK, Pellegrino MA, Ferrone S. The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells. Immunogenetics 1983;18:23-35. (Pubitemid 13025768)
-
(1983)
Immunogenetics
, vol.18
, Issue.1
, pp. 23-35
-
-
Russo, C.1
Ng, A.K.2
Pellegrino, M.A.3
Ferrone, S.4
-
26
-
-
67650270386
-
Identification of human MHC class I binding peptides using the iT
-
Wulf M, Hoehn P, Trinder P. Identification of human MHC class I binding peptides using the iT. Methods Mol Biol 2009;524:361-7.
-
(2009)
Methods Mol Biol
, vol.524
, pp. 361-367
-
-
Wulf, M.1
Hoehn, P.2
Trinder, P.3
-
27
-
-
48249119076
-
Identification and functional validation of MHC class I epitopes in the tumor-associated antigen 5T4
-
Shingler WH, Chikoti P, Kingsman SM, Harrop R. Identification and functional validation of MHC class I epitopes in the tumor-associated antigen 5T4. Int Immunol 2008;20:1057-66.
-
(2008)
Int Immunol
, vol.20
, pp. 1057-1066
-
-
Shingler, W.H.1
Chikoti, P.2
Kingsman, S.M.3
Harrop, R.4
-
28
-
-
0030971268
-
b beta2m double knockout mice
-
DOI 10.1084/jem.185.12.2043
-
Pascolo S, Bervas N, Ure JM, Smith AG, Lemonnier FA, Perarnau B. HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice. J Exp Med 1997;185:2043-51. (Pubitemid 27265987)
-
(1997)
Journal of Experimental Medicine
, vol.185
, Issue.12
, pp. 2043-2051
-
-
Pascolo, S.1
Bervas, N.2
Ure, J.M.3
Smith, A.G.4
Lemonnier, F.A.5
Perarnau, B.6
-
29
-
-
0024354304
-
Determination of subcutaneous tumor size in athymic (nude) mice
-
DOI 10.1007/BF00300234
-
Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 1989;24:148-54. (Pubitemid 19163397)
-
(1989)
Cancer Chemotherapy and Pharmacology
, vol.24
, Issue.3
, pp. 148-154
-
-
Tomayko, M.M.1
Reynolds, C.P.2
-
30
-
-
0034125194
-
Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies
-
DOI 10.1038/76243
-
Trojan A, Schultze JL, Witzens M, Vonderheide RH, Ladetto M, Donovan JW, et al. Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies. Nat Med 2000;6:667-72. (Pubitemid 30398790)
-
(2000)
Nature Medicine
, vol.6
, Issue.6
, pp. 667-672
-
-
Trojan, A.1
Schultze, J.L.2
Witzens, M.3
Vonderheide, R.H.4
Ladetto, M.5
Donovan, J.W.6
Gribben, J.G.7
-
31
-
-
80052061603
-
Clinical significance of productive immunoglobulin heavy chain gene rearrangements in childhood acute lymphoblastic leukemia
-
Katsibardi K, Braoudaki M, Papathanasiou C, Karamolegou K, Tzortzatou-Stathopoulou F. Clinical significance of productive immunoglobulin heavy chain gene rearrangements in childhood acute lymphoblastic leukemia. Leuk Lymphoma 2011;52:1751-7.
-
(2011)
Leuk Lymphoma
, vol.52
, pp. 1751-1757
-
-
Katsibardi, K.1
Braoudaki, M.2
Papathanasiou, C.3
Karamolegou, K.4
Tzortzatou-Stathopoulou, F.5
-
32
-
-
0025855156
-
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
-
Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991;351:290-6. (Pubitemid 21896578)
-
(1991)
Nature
, vol.351
, Issue.6324
, pp. 290-296
-
-
Falk, K.1
Rotzschke, O.2
Stevanovic, S.3
Jung, G.4
Rammensee, H.-G.5
-
33
-
-
0026728457
-
Emerging principles for the recognition of peptide antigens by MHC class I molecules
-
Matsumura M, Fremont DH, Peterson PA, Wilson IA. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 1992;257:927-34.
-
(1992)
Science
, vol.257
, pp. 927-934
-
-
Matsumura, M.1
Fremont, D.H.2
Peterson, P.A.3
Wilson, I.A.4
-
34
-
-
0037961092
-
+ T cell epitopes identified in US adolescent minorities
-
Sabbaj S, Bansal A, Ritter GD, Perkins C, Edwards BH, Gough E, et al. Cross-reactive CD8+ T cell epitopes identified in US adolescent minorities. J Acquir Immune Defic Syndr 2003;33:426-38. (Pubitemid 36886072)
-
(2003)
Journal of Acquired Immune Deficiency Syndromes
, vol.33
, Issue.4
, pp. 426-438
-
-
Sabbaj, S.1
Bansal, A.2
Ritter, G.D.3
Perkins, C.4
Edwards, B.H.5
Gough, E.6
Tang, J.7
Szinger, J.J.8
Korber, B.9
Wilson, C.M.10
Kaslow, R.A.11
Mulligan, M.J.12
Goepfert, P.A.13
-
35
-
-
4644299613
-
Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from Southern Africa
-
Masemola AM, Mashishi TN, Khoury G, Bredell H, Paximadis M, Mathebula T, et al. Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa. J Immunol 2004;173:4607-17. (Pubitemid 39280694)
-
(2004)
Journal of Immunology
, vol.173
, Issue.7
, pp. 4607-4617
-
-
Masemola, A.M.1
Mashishi, T.N.2
Khoury, G.3
Bredell, H.4
Paximadis, M.5
Mathebula, T.6
Barkhan, D.7
Puren, A.8
Vardas, E.9
Colvin, M.10
Zijenah, L.11
Katzenstein, D.12
Musonda, R.13
Allen, S.14
Kumwenda, N.15
Taha, T.16
Gray, G.17
McIntyre, J.18
Karim, S.A.19
Sheppard, H.W.20
Gray, C.M.21
Klautzman, M.22
Kumwenda, N.23
Aquino, V.24
Chirenje, M.25
Mbizo, M.26
Tobaiwa, O.27
Mafhandu, A.28
Msweli, D.29
Dlamini, W.30
Ramjee, G.31
Karim, Q.A.32
Morris, L.33
Taylor, N.34
Williamson, C.35
Rademayer, C.36
Flores, J.37
Cates, W.38
McNeil, L.39
Allen, M.40
more..
-
36
-
-
0031571258
-
Degenerate and Promiscuous Recognition by CTL of Peptides Presented by the MHC Class I A3-like Superfamily: Implications for Vaccine Development
-
Threlkeld SC, Wentworth PA, Kalams SA, Wilkes BM, Ruhl DJ, Keogh E, et al. Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: implications for vaccine development. J Immunol 1997;159:1648-57. (Pubitemid 127484148)
-
(1997)
Journal of Immunology
, vol.159
, Issue.4
, pp. 1648-1657
-
-
Threlkeld, S.C.1
Wentworth, P.A.2
Kalams, S.A.3
Wilkes, B.M.4
Ruhl, D.J.5
Keogh, E.6
Sidney, J.7
Southwood, S.8
Walker, B.D.9
Sette, A.10
-
37
-
-
0041845058
-
Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: Biological validation of the proposed HLA A24 supertype
-
Burrows SR, Elkington RA, Miles JJ, Green KJ, Walker S, Haryana SM, et al. Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: biological validation of the proposed HLA A24 supertype. J Immunol 2003;171:1407-12. (Pubitemid 36900074)
-
(2003)
Journal of Immunology
, vol.171
, Issue.3
, pp. 1407-1412
-
-
Burrows, S.R.1
Elkington, R.A.2
Miles, J.J.3
Green, K.J.4
Walker, S.5
Haryana, S.M.6
Moss, D.J.7
Dunckley, H.8
Burrows, J.M.9
Khanna, R.10
-
38
-
-
34548794906
-
Extensive HLA class I allele promiscuity among viral CTL epitopes
-
DOI 10.1002/eji.200737365
-
Frahm N, Yusim K, Suscovich TJ, Adams S, Sidney J, Hraber P, et al. Extensive HLA class I allele promiscuity among viral CTL epitopes. Eur J Immunol 2007;37:2419-33. (Pubitemid 47423613)
-
(2007)
European Journal of Immunology
, vol.37
, Issue.9
, pp. 2419-2433
-
-
Frahm, N.1
Yusim, K.2
Suscovich, T.J.3
Adams, S.4
Sidney, J.5
Hraber, P.6
Hewitt, H.S.7
Linde, C.H.8
Kavanagh, D.G.9
Woodberry, T.10
Henry, L.M.11
Faircloth, K.12
Listgarten, J.13
Kadie, C.14
Jojic, N.15
Sango, K.16
Brown, N.V.17
Pae, E.18
Zaman, M.T.19
Bihl, F.20
Kahtri, A.21
John, M.22
Mallal, S.23
Marincola, F.M.24
Walker, B.D.25
Sette, A.26
Heckerman, D.27
Korber, B.T.28
Brander, C.29
more..
-
39
-
-
0025868554
-
A single amino acid substitution in an MHC class I molecule allows heteroclitic recognition by lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes
-
Muller D, Pederson K, Murray R, Frelinger JA. A single amino acid substitution in an MHC class I molecule allows heteroclitic recognition by lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes. J Immunol 1991;147:1392-7.
-
(1991)
J Immunol
, vol.147
, pp. 1392-1397
-
-
Muller, D.1
Pederson, K.2
Murray, R.3
Frelinger, J.A.4
-
40
-
-
18144437002
-
Heteroclitic immunization induces tumor immunity
-
DOI 10.1084/jem.188.9.1553
-
Dyall R, Bowne WB, Weber LW, LeMaoult J, Szabo P, Moroi Y, et al. Heteroclitic immunization induces tumor immunity. J Exp Med 1998;188:1553-61. (Pubitemid 28516100)
-
(1998)
Journal of Experimental Medicine
, vol.188
, Issue.9
, pp. 1553-1561
-
-
Dyall, R.1
Bowne, W.B.2
Weber, L.W.3
LeMaoult, J.4
Szabo, P.5
Moroi, Y.6
Piskun, G.7
Lewis, J.J.8
Houghton, A.N.9
Nikolic-Zugic, J.10
-
41
-
-
0031890206
-
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
-
DOI 10.1038/nm0398-321
-
Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL, et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med 1998;4:321-7. (Pubitemid 28144091)
-
(1998)
Nature Medicine
, vol.4
, Issue.3
, pp. 321-327
-
-
Rosenberg, S.A.1
Yang, J.C.2
Schwartzentruber, D.J.3
Hwu, P.4
Marincola, F.M.5
Topalian, S.L.6
Restifo, N.P.7
Dudley, M.E.8
Schwarz, S.L.9
Spiess, P.J.10
Wunderlich, J.R.11
Parkhurst, M.R.12
Kawakami, Y.13
Seipp, C.A.14
Einhorn, J.H.15
White, D.E.16
-
42
-
-
0035892122
-
Induction of cytotoxic T-cell responses against immunoglobulin V region-derived peptides modified at human leukocyte antigen-A2 binding residues
-
Harig S, Witzens M, Krackhardt AM, Trojan A, Barrett P, Broderick R, et al. Induction of cytotoxic T-cell responses against immunoglobulin V region-derived peptides modified at human leukocyte antigen-A2 binding residues. Blood 2001;98:2999-3005.
-
(2001)
Blood
, vol.98
, pp. 2999-3005
-
-
Harig, S.1
Witzens, M.2
Krackhardt, A.M.3
Trojan, A.4
Barrett, P.5
Broderick, R.6
-
43
-
-
4644324025
-
Cancer immunotherapy: Moving beyond current vaccines
-
DOI 10.1038/nm1100
-
Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: moving beyond current vaccines. Nat Med 2004;10:909-15. (Pubitemid 39273730)
-
(2004)
Nature Medicine
, vol.10
, Issue.9
, pp. 909-915
-
-
Rosenberg, S.A.1
Yang, J.C.2
Restifo, N.P.3
-
44
-
-
67651100890
-
Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma
-
Ai WZ, Tibshirani R, Taidi B, Czerwinski D, Levy R. Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma. Blood 2009;113:5743-6.
-
(2009)
Blood
, vol.113
, pp. 5743-5746
-
-
Ai, W.Z.1
Tibshirani, R.2
Taidi, B.3
Czerwinski, D.4
Levy, R.5
-
45
-
-
80052845092
-
Targeting human B-cell malignancies through Ig light chain-specific cytotoxic T lymphocytes
-
Weng J, Cha SC, Matsueda S, Alatrash G, Popescu MS, Yi Q, et al. Targeting human B-cell malignancies through Ig light chain-specific cytotoxic T lymphocytes. Clin Cancer Res 2011;17:5945-52.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 5945-5952
-
-
Weng, J.1
Cha, S.C.2
Matsueda, S.3
Alatrash, G.4
Popescu, M.S.5
Yi, Q.6
|